Literature DB >> 21705486

Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.

Chong-Bin Zhu1, Kathryn M Lindler, Nicholas G Campbell, James S Sutcliffe, William A Hewlett, Randy D Blakely.   

Abstract

Activation of A₃ adenosine receptors (A₃ARs) rapidly enhances the activity of antidepressant-sensitive serotonin (5-HT) transporters (SERTs) in vitro, ex vivo, and in vivo. A₃AR agonist stimulation of SERT activity is lost in A₃AR knockout mice. A₃AR-stimulated SERT activity is mediated by protein kinase G1 (PKGI)- and p38 mitogen-activated protein kinase (MAPK)-linked pathways that support, respectively, enhanced SERT surface expression and catalytic activation. The mechanisms by which A₃ARs target SERTs among other potential effectors is unknown. Here we present evidence that A₃ARs are coexpressed with SERT in midbrain serotonergic neurons and form a physical complex in A₃AR/hSERT cotransfected cells. Treatment of A₃AR/SERT-cotransfected Chinese hamster ovary cells with the A₃AR agonist N⁶-(3-iodobenzyl)-N-methyl-5'-carbamoyladenosine (1 μM, 10 min), conditions previously reported to increase SERT surface expression and 5-HT uptake activity, enhanced the abundance of A₃AR/SERT complexes in a PKGI-dependent manner. Cotransfection of SERT with L90V-A₃AR, a hyperfunctional coding variant identified in subjects with autism spectrum disorder, resulted in a prolonged recovery of receptor/transporter complexes after A₃AR activation. Because PKGI and nitric-oxide synthetase are required for A₃AR stimulation of SERT activity, and proteins PKGI and NOS both form complexes with SERT, our findings suggest a mechanism by which signaling pathways coordinating A₃AR signaling to SERT can be spatially restricted and regulated, as well as compromised by neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705486      PMCID: PMC3164334          DOI: 10.1124/mol.111.071399

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  38 in total

1.  Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.

Authors:  A L Bauman; S Apparsundaram; S Ramamoorthy; B E Wadzinski; R A Vaughan; R D Blakely
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Adenosine A3 receptors are located in neurons of the rat hippocampus.

Authors:  Luísa V Lopes; Nelson Rebola; Paulo C Pinheiro; Peter J Richardson; Catarina R Oliveira; Rodrigo A Cunha
Journal:  Neuroreport       Date:  2003-08-26       Impact factor: 1.837

3.  Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells.

Authors:  Wenying Ren; Stephanie W Watts; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-24       Impact factor: 5.464

4.  Activity of the A3 adenosine receptor gene promoter in transgenic mice: characterization of previously unidentified sites of expression.

Authors:  Ron Yaar; Edward D Lamperti; Paul A Toselli; Katya Ravid
Journal:  FEBS Lett       Date:  2002-12-18       Impact factor: 4.124

5.  Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).

Authors:  Twum-Ampofo Ansah; Sammanda Ramamoorthy; Sylvia Montañez; Lynette C Daws; Randy D Blakely
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

6.  Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.

Authors:  C A Salvatore; S L Tilley; A M Latour; D S Fletcher; B H Koller; M A Jacobson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

7.  Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation.

Authors:  W R Dostmann; M S Taylor; C K Nickl; J E Brayden; R Frank; W J Tegge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 8.  Physiological genomics of antidepressant targets: keeping the periphery in mind.

Authors:  R D Blakely
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

9.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.

Authors:  Chong-Bin Zhu; William A Hewlett; Igor Feoktistov; Italo Biaggioni; Randy D Blakely
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

View more
  20 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Role of nitric oxide in the behavioral and neurochemical effects of IB-MECA in zebrafish.

Authors:  Caio Maximino; Julliany Gemaque; Rancés Benzecry; Monica Gomes Lima; Evander de Jesus Oliveira Batista; Domingos Wanderley Picanço-Diniz; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  Psychopharmacology (Berl)       Date:  2014-11-13       Impact factor: 4.530

3.  Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.

Authors:  Iolanda D'Alimonte; Eleonora Nargi; Mariachiara Zuccarini; Paola Lanuti; Patrizia Di Iorio; Patricia Giuliani; Lucia Ricci-Vitiani; Roberto Pallini; Francesco Caciagli; Renata Ciccarelli
Journal:  Purinergic Signal       Date:  2015-05-15       Impact factor: 3.765

4.  Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.

Authors:  Dilip K Tosh; Silvia Paoletta; Khai Phan; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2012-06-11       Impact factor: 4.345

5.  Cyclic GMP-dependent stimulation of serotonin transport does not involve direct transporter phosphorylation by cGMP-dependent protein kinase.

Authors:  Albert Wong; Yuan-Wei Zhang; Grace R Jeschke; Benjamin E Turk; Gary Rudnick
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

6.  Quantitative trait loci mapping and gene network analysis implicate protocadherin-15 as a determinant of brain serotonin transporter expression.

Authors:  R Ye; A M D Carneiro; Q Han; D Airey; E Sanders-Bush; B Zhang; L Lu; R Williams; R D Blakely
Journal:  Genes Brain Behav       Date:  2014-02-06       Impact factor: 3.449

7.  Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation.

Authors:  Jerry C Chang; Ian D Tomlinson; Michael R Warnement; Alessandro Ustione; Ana M D Carneiro; David W Piston; Randy D Blakely; Sandra J Rosenthal
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

Review 8.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

Review 9.  The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction.

Authors:  Gary Rudnick; Reinhard Krämer; Randy D Blakely; Dennis L Murphy; Francois Verrey
Journal:  Pflugers Arch       Date:  2013-12-13       Impact factor: 3.657

10.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.